NovoCure Ltd.
(NASDAQ : NVCR)

( )
NVCR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.02%477.941.0%$753.43m
DHRDanaher Corp. -0.06%237.150.7%$651.68m
MDTMedtronic Plc -0.01%123.890.6%$614.52m
ABTAbbott Laboratories 0.47%122.010.8%$604.12m
ALGNAlign Technology, Inc. 0.00%594.936.3%$358.42m
ISRGIntuitive Surgical, Inc. 0.00%785.832.3%$347.03m
SYKStryker Corp. -0.02%252.251.3%$298.93m
NVCRNovoCure Ltd. 0.00%186.006.8%$279.45m
DXCMDexCom, Inc. 0.00%391.107.8%$277.48m
BDXBecton, Dickinson & Co. 0.12%250.111.0%$275.09m
BSXBoston Scientific Corp. -0.03%39.661.0%$244.85m
IDXXIDEXX Laboratories, Inc. 0.00%514.163.7%$223.91m
BAXBaxter International, Inc. 0.07%84.701.8%$220.94m
EWEdwards Lifesciences Corp. -0.04%86.220.4%$220.84m
AAgilent Technologies, Inc. -0.08%131.871.6%$187.81m

Company Profile

NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.